A and B antigen levels acquired by group O donor-derived erythrocytes following ABO-non-identical transfusion or minor ABO-incompatible haematopoietic stem cell transplantation
(2017) In Transfusion Medicine 27(3). p.181-191- Abstract
 BACKGROUND AND OBJECTIVES: ABO-incompatible haematopoietic stem cell transplantation (HSCT) presents a challenge to blood component transfusion. The aim of this study was to investigate the weak blood group A or B antigen expression by donor-derived group O red blood cells (RBC) observed following transfusion or minor ABO-incompatible HSCT. In addition, in vitro experiments were performed to elucidate possible mechanisms underlying this phenomenon.
MATERIALS AND METHODS: A sensitive flow cytometry assay for the semi-quantification of RBC A/B antigen levels was used to assess patient samples and evaluate in vitro experiments.
RESULTS: Analysis of blood samples from patients, originally typed as A, B and AB but recently... (More)
BACKGROUND AND OBJECTIVES: ABO-incompatible haematopoietic stem cell transplantation (HSCT) presents a challenge to blood component transfusion. The aim of this study was to investigate the weak blood group A or B antigen expression by donor-derived group O red blood cells (RBC) observed following transfusion or minor ABO-incompatible HSCT. In addition, in vitro experiments were performed to elucidate possible mechanisms underlying this phenomenon.
MATERIALS AND METHODS: A sensitive flow cytometry assay for the semi-quantification of RBC A/B antigen levels was used to assess patient samples and evaluate in vitro experiments.
RESULTS: Analysis of blood samples from patients, originally typed as A, B and AB but recently transplanted or transfused with cells from group O donors, revealed the A antigen expression on donor-derived RBC, ranging from very low levels in non-secretor individuals to almost subgroup Ax -like profiles in group A secretors. The B antigen expression was less readily detectable. In vitro experiments, in which group O donor RBC were incubated with (i) group A/B secretor/non-secretor donor plasma or (ii) group A/B donor RBC in the absence of plasma, supported the proposed adsorption of A/B antigen-bearing glycolipids from secretor plasma but also indicated a secretor-independent mechanism for A/B antigen acquisition as well as direct cell-to-cell transfer of ABO antigens.
CONCLUSION: The in vivo conversion of donor-derived blood group O RBC to ABO subgroup-like RBC after transfusion or minor ABO-incompatible HSCT raises the question of appropriate component selection. Based on these data, AB plasma should be transfused following ABO-incompatible HSCT.
(Less)
- author
 - 						Hult, A K
				LU
	; 						Dykes, J H
				LU
	; 						Storry, J R
				LU
	 and 						Olsson, M L
				LU
				
	 - organization
 - publishing date
 - 2017-04-12
 - type
 - Contribution to journal
 - publication status
 - published
 - subject
 - keywords
 - Journal Article
 - in
 - Transfusion Medicine
 - volume
 - 27
 - issue
 - 3
 - pages
 - 181 - 191
 - publisher
 - Wiley-Blackwell
 - external identifiers
 - 
                
- pmid:28401678
 - scopus:85017521770
 - wos:000404200800004
 
 - ISSN
 - 0958-7578
 - DOI
 - 10.1111/tme.12411
 - language
 - English
 - LU publication?
 - yes
 - id
 - c5bebf8f-7faf-4ee1-900c-2ccd20a296a6
 - date added to LUP
 - 2017-04-29 18:57:28
 - date last changed
 - 2025-10-14 11:25:35
 
@article{c5bebf8f-7faf-4ee1-900c-2ccd20a296a6,
  abstract     = {{<p>BACKGROUND AND OBJECTIVES: ABO-incompatible haematopoietic stem cell transplantation (HSCT) presents a challenge to blood component transfusion. The aim of this study was to investigate the weak blood group A or B antigen expression by donor-derived group O red blood cells (RBC) observed following transfusion or minor ABO-incompatible HSCT. In addition, in vitro experiments were performed to elucidate possible mechanisms underlying this phenomenon.</p><p>MATERIALS AND METHODS: A sensitive flow cytometry assay for the semi-quantification of RBC A/B antigen levels was used to assess patient samples and evaluate in vitro experiments.</p><p>RESULTS: Analysis of blood samples from patients, originally typed as A, B and AB but recently transplanted or transfused with cells from group O donors, revealed the A antigen expression on donor-derived RBC, ranging from very low levels in non-secretor individuals to almost subgroup Ax -like profiles in group A secretors. The B antigen expression was less readily detectable. In vitro experiments, in which group O donor RBC were incubated with (i) group A/B secretor/non-secretor donor plasma or (ii) group A/B donor RBC in the absence of plasma, supported the proposed adsorption of A/B antigen-bearing glycolipids from secretor plasma but also indicated a secretor-independent mechanism for A/B antigen acquisition as well as direct cell-to-cell transfer of ABO antigens.</p><p>CONCLUSION: The in vivo conversion of donor-derived blood group O RBC to ABO subgroup-like RBC after transfusion or minor ABO-incompatible HSCT raises the question of appropriate component selection. Based on these data, AB plasma should be transfused following ABO-incompatible HSCT.</p>}},
  author       = {{Hult, A K and Dykes, J H and Storry, J R and Olsson, M L}},
  issn         = {{0958-7578}},
  keywords     = {{Journal Article}},
  language     = {{eng}},
  month        = {{04}},
  number       = {{3}},
  pages        = {{181--191}},
  publisher    = {{Wiley-Blackwell}},
  series       = {{Transfusion Medicine}},
  title        = {{A and B antigen levels acquired by group O donor-derived erythrocytes following ABO-non-identical transfusion or minor ABO-incompatible haematopoietic stem cell transplantation}},
  url          = {{https://lup.lub.lu.se/search/files/31175539/24684808.pdf}},
  doi          = {{10.1111/tme.12411}},
  volume       = {{27}},
  year         = {{2017}},
}